Disease · HP_0000855

Comparisons in its trials51

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 20 of 51

Download this page as JSON

Comparison	Group 1, with the outcome	Group 2, with the outcome	Participants	Trial	Source
Orlistat vs Placebo: serious adverse events	0 of 100	2 of 100	200	NCT00001723	Trial comparisons
Tadalafil vs Placebo: deaths from any cause	0 of 61	0 of 64	125	NCT02819440	Trial comparisons
Tadalafil vs Placebo: serious adverse events	0 of 61	0 of 64	125	NCT02819440	Trial comparisons
Metformin Plus Weight Reduction Counseling vs Placebo Plus Weight Reduction Counseling: serious adverse events	0 of 53	0 of 47	100	NCT00005669	Trial comparisons
Pioglitazone vs Placebo: serious adverse events	11 of 48	10 of 47	95	NCT01301027	Trial comparisons
Tadalafil vs Placebo: serious adverse events	0 of 36	0 of 37	73	NCT01444651	Trial comparisons
Salsalate Therapy vs Placebo: serious adverse events	0 of 34	0 of 36	70	NCT00330733	Trial comparisons
Diet Intervention vs GLP-1 Intervention: deaths from any cause	0 of 17	0 of 38	55	NCT03919929	Trial comparisons
Diet Intervention vs GLP-1 Intervention: serious adverse events	0 of 17	0 of 38	55	NCT03919929	Trial comparisons
Pitavastatin vs Placebo: deaths from any cause	0 of 25	0 of 25	50	NCT02290106	Trial comparisons
Pitavastatin vs Placebo: serious adverse events	2 of 25	1 of 25	50	NCT02290106	Trial comparisons
Aliskiren 300mg vs Amlodipine 5mg: serious adverse events	0 of 23	0 of 25	48	NCT00417170	Trial comparisons
Metformin vs Placebo: deaths from any cause	0 of 25	0 of 23	48	NCT01808690	Trial comparisons
Metformin vs Placebo: serious adverse events	0 of 25	0 of 23	48	NCT01808690	Trial comparisons
Sildenafil vs Placebo: serious adverse events	0 of 23	0 of 23	46	NCT01334554	Trial comparisons
Pioglitazone vs Placebo: serious adverse events	0 of 30	0 of 15	45	NCT02192684	Trial comparisons
Amlexanox vs Placebo: deaths from any cause	0 of 21	0 of 21	42	NCT01975935	Trial comparisons
Amlexanox vs Placebo: serious adverse events	1 of 21	1 of 21	42	NCT01975935	Trial comparisons
Salsalate 3500mg in 2 Divided Doses a Day vs Placebo: serious adverse events	0 of 27	0 of 14	41	NCT02007577	Trial comparisons
Metformin vs Placebo: deaths from any cause	0 of 20	0 of 20	40	NCT03733132	Trial comparisons

diseases-2026-09-18-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/HP_0000855/comparisons

API reference For AI assistants

Comparisons in its trials51

Sources 6

Read this list from software.